Challenges with Defining Pharmaceutical Markets and Potential Remedies to Screen for Industry Consolidation

Robin Feldman, Brent D. Fulton, Jamie R. Godwin, Richard M. Scheffler

Open source

DOI
10.1215/03616878-9978131
Published
2022-10-01
Container
Journal of Health Politics, Policy and Law
Publisher
Duke University Press
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1215/03616878-9978131,
  title = {Challenges with Defining Pharmaceutical Markets and Potential Remedies to Screen for Industry Consolidation},
  author = {Robin Feldman and Brent D. Fulton and Jamie R. Godwin and Richard M. Scheffler},
  year = {2022},
  journal = {Journal of Health Politics, Policy and Law},
  doi = {10.1215/03616878-9978131},
  url = {https://doi.org/10.1215/03616878-9978131}
}

RIS

TY  - JOUR
TI  - Challenges with Defining Pharmaceutical Markets and Potential Remedies to Screen for Industry Consolidation
AU  - Robin Feldman
AU  - Brent D. Fulton
AU  - Jamie R. Godwin
AU  - Richard M. Scheffler
PY  - 2022
JO  - Journal of Health Politics, Policy and Law
DO  - 10.1215/03616878-9978131
UR  - https://doi.org/10.1215/03616878-9978131
ER  - 

APA

Feldman, R., Fulton, B. D., Godwin, J. R., & Scheffler, R. M. (2022). Challenges with Defining Pharmaceutical Markets and Potential Remedies to Screen for Industry Consolidation. Journal of Health Politics, Policy and Law. https://doi.org/10.1215/03616878-9978131

Source records